Orally administered poly-γ-glutamic acid enhances mucosal immune responses through production of intestinal chemokines and activation of mucosal dendritic cells

Jihyun Yang,Eunjin Kim,Jaemoo Kim,Haryoung Poo
DOI: https://doi.org/10.4049/jimmunol.200.supp.172.13
2018-05-01
The Journal of Immunology
Abstract:Abstract The oral administration of poly-gamma glutamic acid (γ-PGA), a safe and edible biomaterial naturally secreted by Bacillus subtilis sups. Chungkookjang, has been reported to enhance the anti-tumor immunity. After the oral uptake of γ-PGA, the underlying mechanism to affect the mucosal and systemic immune responses has not been displayed yet. Thus we checked the mucosal immune response induced by γ-PGA, such as the production of intestinal chemokines and the activation of mucosal dendritic cells. Upon oral administration of γ-PGA in mice, the presence of γ-PGA was observed in subepithelial dome region of peyer’s patch (PP). Orally administered γ-PGA enhanced levels of various chemokines in intestines, activation of DCs in PPs and accumulation of CD8− DC subsets in mesenteric lymph nodes. Oral administration of γ-PGA mixed with ovalbumin (OVA) as a model antigen increased activation of OVA-specific T cells and levels of both intestinal IgA and sera IgG compared with mice received OVA alone. Moreover, the γ-PGA-OVA group robustly suppressed tumor growth and increased survival in a murine cancer model seeded with the B16mOVA cells, which are B16 expressing membrane-bound OVA, compared to the OVA group. Taken together, these results suggest that γ-PGA induce the mucosal immune responses by enhancing the production of intestinal chemokines and the activation of mucosal dendritic cells, which lead to the increase of the anti-tumor immunity.
immunology
What problem does this paper attempt to address?